
The challenging reality of refusal of care
Few situations create more anxiety in healthcare than when a patient refuses recommended treatment. In obstetrics, those situations can be particularly complex because decisions often affect both the mother and the unborn child. The resulting tension can place clinicians at the intersection of ethics, clinical judgment, legal considerations, cultural beliefs and risk management.
While many healthcare professionals immediately think of a patient signing out against medical advice (AMA), refusal of care takes many forms. A patient may decline only one component of a treatment plan while accepting all other recommendations. She may refuse medication, a procedure, a blood transfusion, or a cesarean delivery. She may choose to leave before treatment is initiated or leave unexpectedly without notice such as in the case of elopement. Each type of refusal presents a unique set of clinical, ethical, and legal risks that require thoughtful management.
For risk managers, these cases often become focal points in subsequent reviews, adverse event investigations and malpractice litigation. Questions surrounding informed consent, informed refusal, documentation and patient understanding frequently become central to the analysis.
Informed consent is more than a signature
The foundation for managing informed refusal begins with understanding informed consent.
A common misconception is that informed consent is merely a form that requires a signature. In reality, informed consent is a communication process. It is a shared decision-making conversation between the healthcare team and the patient that facilitates understanding, supports autonomy and promotes informed choices.
Effective informed consent includes discussion of:
- The proposed treatment or intervention
- The expected benefits
- The associated risks
- Available alternatives
- The risks of declining treatment
- The opportunity for the patient to ask questions
The American College of Obstetricians and Gynecologists (ACOG) emphasizes that informed consent should be individualized, patient-centered, and built around shared decision-making (ACOG Committee Opinion No. 819, 2021). The goal is not simply obtaining agreement but ensuring meaningful understanding.
For maternal health patients, informed consent should not be viewed as a one-time event occurring during labor. Rather, it should be an ongoing process throughout pregnancy. Prenatal visits create opportunities to discuss interventions that may become necessary later, allowing patients to consider information in a calmer environment rather than during a medical emergency.
Shared decision-making and patient-centered care
When a patient refuses care, the first step is often the simplest: listen.
Healthcare teams sometimes focus immediately on the clinical implications of the refusal while overlooking the reasons driving the decision. Yet understanding the underlying concern may reveal solutions that preserve both patient autonomy and clinical safety.
Refusals may be influenced by:
- Cultural beliefs
- Religious convictions
- Previous healthcare experiences
- Family dynamics
- Social determinants of health
- Fear or mistrust
- Personal preferences
- Misunderstanding of risks or benefits
Sometimes the issue has a practical solution.
One example involved a 32-year-old pregnant patient at 35 weeks' gestation who presented to the hospital with severe preeclampsia and was advised to remain hospitalized for maternal and fetal monitoring. During the informed consent discussion, the patient initially refused admission despite understanding the risks of seizure, stroke, placental abruption and fetal compromise.
Further conversation revealed that she was the sole caregiver for her elderly mother, who had dementia and was alone at home. The patient expressed significant anxiety about leaving her mother unattended and stated that this concern was driving her decision to leave the hospital.
The care team worked with social work and case management, who engaged with family members to arrange temporary caregiving support. Once those home logistics were addressed, the patient agreed to remain hospitalized and continue the recommended plan of care.
Documentation reflected the patient's initial refusal, the underlying reason for refusal, assessment of decision-making capacity, the informed discussion of risks and benefits, interventions undertaken to address the patient's concerns, and the patient's ultimate acceptance of treatment.
This case illustrates the importance of exploring the reason behind a refusal, as barriers to care may sometimes be resolved through patient-centered problem solving rather than confrontation or coercion.
The lesson is clear: refusal often represents a symptom of deeper concern. Listening may reveal barriers that can be addressed without compromising care.
Refusal does not mean care stops
An important misconception among clinicians is that refusal of one aspect of treatment means the patient is rejecting all care.
This is rarely the case.
Patients who decline one intervention should continue receiving appropriate care, education, discharge planning, medications and follow-up recommendations. Healthcare organizations should strive to maintain a therapeutic relationship even when disagreement exists.
For example, if a patient elects to leave against medical advice, clinicians can still:
- Provide discharge instructions
- Offer prescriptions when appropriate
- Explain warning signs and return precautions
- Encourage follow-up care
- Invite the patient to return if circumstances change
- Document all discussions thoroughly
Organizations should consult with their clinical and legal teams to determine the appropriate protocols for their specific setting.
Maintaining continuity of care not only supports patient safety but also may help reduce the risk of allegations of abandonment or coercion.
Common obstetrical refusals
Labor and delivery teams frequently encounter refusals involving:
- Intravenous access
- Medications
- Oxytocin induction or augmentation
- Pelvic examinations
- Prenatal laboratory testing
- Drug screening
- Blood products
- Operative vaginal deliveries (forceps or vacuum)
- Cesarean delivery
Each refusal requires a thoughtful assessment of the patient's understanding and decision-making capacity, as well as careful documentation of discussions regarding risks, benefits, and alternatives.
Education remains one of the most powerful tools available to clinicians. Information should be communicated in a way that matches the patient's level of understanding and preferred language. Clinicians should use professional interpreter services whenever language barriers exist.
The most difficult scenario: refusal during an emergency
Perhaps the most emotionally difficult situations occur when a competent patient refuses a potentially life-saving intervention during an obstetrical emergency.
Consider a scenario in which fetal distress develops during labor and a cesarean section is urgently recommended. Despite understanding the risks, the patient declines the procedure based on cultural or religious beliefs. Family members support her decision. The patient retains decision-making capacity.
For clinicians, these moments can be extraordinarily distressing.
Many providers experience profound moral distress when they believe an intervention could prevent injury or death, yet the patient chooses otherwise. Nurses, physicians, and support staff may feel helpless as events unfold.
In these circumstances, established best practice frameworks suggest an interdisciplinary response that may include:
- Activation of the chain of command
- Ethics consultation
- Risk management consultation
- Legal consultation
- Participation of cultural or religious representatives
- Palliative care involvement when appropriate
Ethics teams can help facilitate difficult conversations and support decision-making. Palliative care specialists may provide valuable support for patients, families, and care teams when outcomes may be poor despite everyone's best efforts.
Legal considerations and state variability
The legal dimensions of maternal refusal cases remain complex.
State laws vary significantly regarding maternal-fetal conflicts and the extent to which courts may become involved when pregnant patients refuse recommended interventions. Consequently, organizations should avoid relying on assumptions and instead engage legal counsel early when high-risk conflicts arise.
Importantly, legal questions should never overshadow the need for respectful, compassionate communication. Even when legal consultation is warranted, preserving trust and minimizing trauma remain essential goals.
Reducing risk through early education
One of the strongest themes emerging from the discussion is the importance of anticipatory education.
Many informed consent conversations still occur during labor when patients are experiencing stress, pain, fatigue and emotional overload. Yet pregnancy provides months of opportunity for preparation.
Organizations should consider shifting conversations regarding:
- Cesarean delivery
- Operative vaginal delivery
- Blood transfusion
- Induction of labor
- Emergency interventions
- Neonatal resuscitation
Early education allows patients to consider their options, ask questions, engage family members and make informed decisions before a crisis occurs.
Key takeaways for risk managers and clinical leaders
Informed refusal cases represent some of the most challenging scenarios in healthcare. They test clinicians' commitment to autonomy while simultaneously raising concerns about safety and preventable harm.
Organizations can strengthen their response by:
- Treating informed consent as a continuing process rather than a signed document
- Encouraging shared decision-making throughout pregnancy
- Exploring the reasons behind refusals through active listening
- Maintaining care even when patients decline recommended interventions
- Supporting clinicians experiencing moral distress
- Leveraging ethics, legal, risk management, and palliative care resources
- Promoting early prenatal education about potential interventions
Ultimately, patients have the right to make informed decisions, even when clinicians disagree with those choices. The role of healthcare professionals is not to coerce decisions but to ensure that choices are informed, understood, documented and supported through compassionate, patient-centered care.
Conclusion
The most important takeaway may be the simplest: never take informed consent for granted. Meaningful conversations, thoughtful listening, and shared decision-making remain the strongest tools available for protecting both patient autonomy and patient safety.
In today's healthcare environment, informed consent should not be viewed as a signature obtained moments before a procedure. Rather, it is a continuous process of education, communication, and relationship-building that occurs throughout the patient's care journey. Every interaction presents an opportunity to assess understanding, address concerns, explore cultural or religious considerations and ensure that patients are making decisions based on accurate and complete information.
When patients refuse recommended care, the strength of the informed consent process becomes even more important. A well-established foundation of trust allows patients to voice concerns openly and gives clinicians the opportunity to better understand the factors influencing decision-making. Often, what initially appears to be a refusal of treatment may stem from fear, misunderstanding, family obligations, financial concerns, cultural beliefs or logistical barriers rather than a rejection of medical advice itself. By approaching these situations with curiosity, empathy and respect, healthcare professionals can uncover opportunities to address underlying concerns while maintaining a therapeutic relationship.
For healthcare leaders, clinicians, and risk managers, the goal is not simply to obtain agreement with a recommended plan of care. The goal is to ensure that every patient feels heard, respected and empowered to participate in decisions affecting their health. Patients have the right to accept or refuse treatment, but they also deserve clear explanations of risks, benefits, alternatives and potential consequences. When those conversations are conducted thoughtfully and documented thoroughly, organizations may be better positioned to support safe care, reduce misunderstandings, help manage liability exposure and uphold ethical standards.
Ultimately, informed consent and informed refusal represent far more than legal requirements. They are fundamental expressions of patient-centered care and respect for individual autonomy. When healthcare teams prioritize communication, foster trust and engage patients as true partners in decision-making, they create an environment where even the most difficult choices can be navigated with compassion, transparency and mutual respect. In the end, the quality of these conversations may be just as important as the clinical interventions themselves.
This article is based on a recorded podcast discussion featuring Joan Porcaro (Willis, a WTW business), Karen Kolega (Chief Nursing Officer, PeriGen), and Debbie Ketchum (Director, Clinical Engagement, PeriGen). The discussion has been synthesized and edited to capture the key themes, insights and recommendations while preserving the substance and intent of the conversation.
Disclaimer
WTW hopes you found the general information provided here informative and helpful. The information contained herein is not intended to constitute legal or other professional advice and should not be relied upon in lieu of consultation with your own legal advisors. In the event you would like more information regarding your insurance coverage, please do not hesitate to reach out to us. In North America, WTW offers insurance products through licensed entities, including Willis Towers Watson Northeast, Inc. (in the United States) and Willis Canada Inc. (in Canada).






